{
    "document_name": "ung-thu-buong-trung-giai-doan-4.json",
    "document_name_accent": "ung thu buong trung giai doan 4.json",
    "document_title": "Stage 4 ovarian cancer: Symptoms, treatment and prognosis",
    "document_category": "Oncology",
    "subsection_name": "ung-thu-buong-trung-giai-doan-4.json_5_How to treat stage IV ovarian cancer",
    "subsection_content": "The treatment of stage IV ovarian cancer is complicated because the cancer cells have metastasized to distant organs. According to MSc. Luu Thao Ngoc, treatment methods focus on the following goals: eliminating cancer cells as much as possible, inhibiting the proliferation of cancer cells, and minimizing symptoms caused by cancer. cause. (5)\nThe main treatment for stage IV ovarian cancer includes:\nStage IV ovarian cancer can be treated with tumor reduction surgery. After surgery, the patient will receive systemic treatment (with drugs such as chemicals, vascular antibiotics, etc.).; In some cases where surgery is not feasible from the beginning, the patient will receive neoadjuvant treatment aimed at shrinking the size of the tumor and metastatic lesions to make surgery more convenient and safer (with chemotherapy and targeted drugs can be used several cycles before surgery), then surgery is performed (also called inter-operative surgery), and systemic treatment continues after surgery with targeted chemicals/drugs, … There is a proportion of patients who do not respond to neoadjuvant chemotherapy regimens that will continue to be treated according to clinical trials or only symptomatic care.\nSurgery\nSurgery to reduce the total tumor mass (debulking) with total hysterectomy and 2 appendages, greater omentectomy, lymph node dissection and maximal removal of peritoneal metastases.\nValence\nThis is a method of using drugs that attack cancer cells to prevent their growth. Usually chemotherapy is used after surgery. However, recent studies show that the role of neoadjuvant chemotherapy (chemotherapy before surgery) has helped shrink tumors, minimize metastatic lesions, and make surgery convenient and safe. than. With stage IV ovarian cancer, chemotherapy is considered the main treatment method.\nCombination chemotherapy regimens between platinum chemotherapy agents (such as carboplatin) and taxane agents (such as paclitaxel, docetaxel) are commonly used and have proven effective in treating patients with ovarian carcinoma. egg.\nBesides the effectiveness of treatment, chemotherapy also causes unwanted side effects for the patient's body such as fatigue, nausea, hair loss, and affects hematological function (such as leukopenia, thrombocytopenia). ,…), liver-kidney dysfunction, etc. Therefore, before starting treatment, the doctor will discuss carefully with the patient about the benefits of treatment and possible side effects so that the patient can understand and notify the treating doctor when experiencing any unwanted side effects and the patient will receive supportive treatment when needed.\nTargeted therapy\nUnderstanding of molecular biological pathways leads to the development of targeted drugs to treat ovarian cancer such as anti-VEGF drugs (such as bevacizumab), PARP inhibitors (olaparib), ...\nImmunotherapy\nMSc. Dr. Luu Thao Ngoc said that immune checkpoint inhibitor therapy is a treatment that is of interest in the research of cancer diseases, including ovarian cancer, and holds great promise in treatment. against tumors. For example, anti-PD-1 monoclonal antibody Pembrolizumab,...",
    "subsection_title": "ung thu buong trung giai doan 4.json. How to treat stage IV ovarian cancer",
    "subsection_data": "ung thu buong trung giai doan 4.json. How to treat stage IV ovarian cancer\nThe treatment of stage IV ovarian cancer is complicated because the cancer cells have metastasized to distant organs. According to MSc. Luu Thao Ngoc, treatment methods focus on the following goals: eliminating cancer cells as much as possible, inhibiting the proliferation of cancer cells, and minimizing symptoms caused by cancer. cause. (5)\nThe main treatment for stage IV ovarian cancer includes:\nStage IV ovarian cancer can be treated with tumor reduction surgery. After surgery, the patient will receive systemic treatment (with drugs such as chemicals, vascular antibiotics, etc.).; In some cases where surgery is not feasible from the beginning, the patient will receive neoadjuvant treatment aimed at shrinking the size of the tumor and metastatic lesions to make surgery more convenient and safer (with chemotherapy and targeted drugs can be used several cycles before surgery), then surgery is performed (also called inter-operative surgery), and systemic treatment continues after surgery with targeted chemicals/drugs, … There is a proportion of patients who do not respond to neoadjuvant chemotherapy regimens that will continue to be treated according to clinical trials or only symptomatic care.\nSurgery\nSurgery to reduce the total tumor mass (debulking) with total hysterectomy and 2 appendages, greater omentectomy, lymph node dissection and maximal removal of peritoneal metastases.\nValence\nThis is a method of using drugs that attack cancer cells to prevent their growth. Usually chemotherapy is used after surgery. However, recent studies show that the role of neoadjuvant chemotherapy (chemotherapy before surgery) has helped shrink tumors, minimize metastatic lesions, and make surgery convenient and safe. than. With stage IV ovarian cancer, chemotherapy is considered the main treatment method.\nCombination chemotherapy regimens between platinum chemotherapy agents (such as carboplatin) and taxane agents (such as paclitaxel, docetaxel) are commonly used and have proven effective in treating patients with ovarian carcinoma. egg.\nBesides the effectiveness of treatment, chemotherapy also causes unwanted side effects for the patient's body such as fatigue, nausea, hair loss, and affects hematological function (such as leukopenia, thrombocytopenia). ,…), liver-kidney dysfunction, etc. Therefore, before starting treatment, the doctor will discuss carefully with the patient about the benefits of treatment and possible side effects so that the patient can understand and notify the treating doctor when experiencing any unwanted side effects and the patient will receive supportive treatment when needed.\nTargeted therapy\nUnderstanding of molecular biological pathways leads to the development of targeted drugs to treat ovarian cancer such as anti-VEGF drugs (such as bevacizumab), PARP inhibitors (olaparib), ...\nImmunotherapy\nMSc. Dr. Luu Thao Ngoc said that immune checkpoint inhibitor therapy is a treatment that is of interest in the research of cancer diseases, including ovarian cancer, and holds great promise in treatment. against tumors. For example, anti-PD-1 monoclonal antibody Pembrolizumab,..."
}